The trademark application SQORE was filed by Comera Life Sciences, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on September 29, 2022, and it was registered by office on January 6, 2023 without any oppositions.
The application was filed in English (German was selected as the second language).
Appointment and Replacement of representative of the trademark registration was recorded on December 21, 2022.
Goods And Services
The mark was filed in class 1 with Excipients for use in the manufacture of and as a component of therapeutic compositions.
The mark was filed in class 5 with following description of goods:
Biologic medicines for medical diagnosis or treatment including biologic medicines, containing excipients, for medical diagnosis or treatment, biologic medicines consisting of therapeutic biologics and excipients, for medical diagnosis or treatment and biologic medicines consisting of monoclonal antibodies and excipients, for medical diagnosis or treatment
Monoclonal antibodies for medical diagnosis or treatment
Antibodies
Medicine.
The mark was filed in class 40 with Manufacturing, processing and treating the therapeutic molecules of others.
The mark was filed in class 42 with following description of goods:
Scientific design and development of excipients for use with therapeutic biologics
Scientific research and design in the field of therapeutic formulation development
Consulting in the fields of therapeutic formulation and excipient development.
The mark was filed in class 45 with Licensing of intellectual property.